Researchers are developing a ribozyme that cleaves the HIV genome. This pharmaceutical agent could be described as
A) an RNA molecule capable of catalysis.
B) a genetic transposable element.
C) a protease inhibitor.
D) a competitive inhibitor for reverse transcriptase.
E) a hydrolase.